PTCT Overview
Upcoming Projects (PTCT)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (PTCT)
-
Examining uniQure's AMT-130 and PTC Therapeutics' PTC518: Data on Slowing Huntington's Disease Progression
Tickers: QURE, PTCT
Executed On: Jul 12, 2024 at 11:15 AM EDT -
Discussing the potential of uniQure's gene therapy AMT-130 and PTC Therapeutics candidate PTC518 in Huntington's Disease.
Tickers: QURE, PTCT
Executed On: Jul 18, 2023 at 12:00 PM EDT -
Discussing the PTC Therapeutics' Phase 3 APHENITY data on Sepiapterin in Phenylketonuria (PKU)
Ticker: PTCT
Executed On: May 23, 2023 at 05:00 PM EDT
Expired Projects (PTCT)
Upcoming & Overdue Catalysts (PTCT)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (PTCT)
-
Phase 2/3 data of RG7916 in Spinal Muscular Atrophy (SMA) to be presented at AAN May 7, 2019 1pm.
Tickers: PTCT, RHHBY
Occurred on: May 07, 2019 -
Preliminary read out of open label Phase 3 study in DMD of eteplirsen
Tickers: SRPT, BMRN, PTCT
Occurred on: Dec 27, 2017 -
Data from First Set of 24-week Biopsies Expected Q2 or Q3 for UK Enrolled DMD patients in the Ongoing PhaseOut DMD trial
Tickers: SMMT, BMRN, SRPT, PTCT
Occurred on: Jun 22, 2017 -
PTCT Withdraws European Marketing Application for Translarna in Cystic Fibrosis
Ticker: PTCT
Occurred on: Mar 24, 2017 -
PTCT Acquires Duchenne Muscular Dystrophy Drug (DMD) Emflaza (Deflazacort) from Marathon Pharmaceuticals
Tickers: PTCT, Marathon Pharmaceuticals
Occurred on: Mar 16, 2017 -
Regulatory review of PTC's Translarna (ataluren) marketing authorization in Europe delayed, renewal expected
Ticker: PTCT
Occurred on: Jul 25, 2016 -
FDA Advisory committee meeting for Sarepta Therapeutics' Eteplirsen
Tickers: SRPT, PTCT, BMRN
Occurred on: Apr 25, 2016 -
PTC Therapeutics Provides Update on Health Canada Review of Translarna (ataluren) for the Treatment of Duchenne Muscular Dystrophy
Ticker: PTCT
Occurred on: Mar 14, 2016 -
FDA decision on Drisapersen approval in DMD: PDUFA 12/27/15
Tickers: BMRN, SRPT, PTCT
Occurred on: Jan 14, 2016 -
FDA Will Review BioMarin's (BMRN) New Drug Application for Duchenne Muscular Dystrophy Candidate Drisapersen on November 24, 2015
Tickers: BMRN, SRPT, PTCT
Occurred on: Nov 24, 2015
Strategic Initiatives (PTCT)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
